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Purpose: Pulmonary Kv channels are thought to play a crucial role in the regulation 
of cell proliferation and apoptosis. Previous studies have shown that fluoxetine up-
regulated the expression of Kv1.5 and prevented pulmonary arterial hypertension in 
monocrotaline-induced or hypoxia-induced rats and mice. The current study was de-
signed to test how fluoxetine regulates Kv1.5 channels, subsequently promoting 
apoptosis in human PASMCs cultured in vitro. Materials and Methods: Human 
PASMCs were incubated with low-serum DMEM, ET-1, and fluoxetine with and 
without ET-1 separately for 72 h. Then the proliferation, apoptosis, and expression of 
TRPC1 and Kv1.5 were detected. Results: In the ET-1 induced group, the upregula-
tion of TRPC1 and down regulation of Kv1.5 enhanced proliferation and anti-apop-
tosis, which was reversed when treated with fluoxetine. The decreased expression of 
TRPC1 increased the expression of Kv1.5, subsequently inhibiting proliferation 
while promoting apoptosis. Conclusion: The results from the present study suggest-
ed that fluoxetine protects against big endothelin-1 induced anti-apoptosis and res-
cues Kv1.5 channels in human pulmonary arterial smooth muscle cells, potentially 
by decreasing intracellular concentrations of Ca2+.
Key Words:    Apoptosis, Kv1.5, human pulmonary arterial smooth muscle cells
INTRODUCTION
The development of pulmonary arterial hypertension (PAH) involves a complex 
constellation of multiple genes and molecules, which interact with each other and 
subsequently activate intracellular signaling pathways that eventually result in pul-
monary remodeling. Vascular remodeling has been confirmed to be a hallmark 
pathological feature of PAH, and is characterized by changes in the pulmonary 
vascular structures associated with medial hypertrophy, which are mainly caused 
by an imbalance between the proliferation and apoptosis of pulmonary arterial 
smooth muscle cells (PASMCs).
Pulmonary Kv channels are thought to play a crucial role in the regulation of cell 
proliferation and apoptosis. K+ fluxes have been implicated in both the early and 
late stages of apoptosis, as the down regulation of Kv has been shown to induce in-
creases in intracellular K+ concentrations ([K+]i) and tonically inhibit caspase, fur-Fluoxetine Rescues Kv1.5
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ShangHai, China), and fluoxetine (F; Sigma-Aldrich, Shang-
Hai, China) with and without ET-1 separately for 72 hours.
MTT assay 
Cell proliferation was quantified by multiply-table tourna-
ment (MTT) assay. Briefly, human PASMCs were plated 
into 96-well microplates at the concentration of 2×103 cells/
well and treated with the different drugs as described 
above. After incubation, 20 μL of the MTT reagent was 
added to each well and the multiwell plates were incubated 
in a humidified atmosphere for 4 hours. Then, the superna-
tant was removed from each well and 200 μL/well of di-
methyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, 
USA) was added  to solubilize the formed formazan salt 
crystals. The solubilized formazan product was spectropho-
tometrically quantified at 570 nm using an ELISA reader 
(Biorad, Hercules, CA, USA). Data were expressed as a % 
of the control.
Reverse transcription-polymerase chain reaction
Total RNA was isolated from human PASMCs using TRIzol 
reagent (Sigma-Aldrich, St. Louis, MO, USA) according to 
the manufacturer’s instructions. The specific primers were 
designed from the coding regions of human Kv1.5 (forward 
primer: 5’-TCCT CCG AGTCATCCG-3’, reverse primer: 
5’-ACAGCGAGCCCACGATC-3’). As a control for the in-
tegrity of RNA, the primers of glyceraldehydes phosphate 
dehydrogenase (GAPDH) were used (forward primer: 5’-A 
GGTGAAGG TCGGAG TCAAC-3’ and reverse primer: 
5’-CGCTCCTGGAAGATGG TGAT-3’). Amplified prod-
ucts were separated by 1.2% agarose gel electrophoresis 
and stained with ethidium bromide. PCR product bands 
were visualized by ultra violet light, and the intensity val-
ues were measured by densitometric analysis with the 
Quantity One program (Bio-Rad) and normalized to the in-
tensity values of GAPDH for quantitative comparisons. 
The PCR product was sequenced and the amplified produc-
tion of human Kv1.5 and GAPDH were 306 and 232 bp, 
respectively.
Western blotting
After 72 hours, cells were harvested in cell lysis solution 
(BioDev-Tech. Company, Beijing, China); then protein was 
extracted. The resultant protein concentrations were deter-
mined by BCA Protein Assay reagents (Beyotime Biotech-
nology, Jiangsu, China). The extracts were diluted in 5× 
loading buffer and heated at 95°C for 5 minutes. Kv1.5 and 
ther suppressing apoptosis. As shown in human and animal 
models of PAH, resistance to apoptosis was further en-
hanced by the selective downregulation of Kv1.5 chan-
nels.1-3 However, increases in Kv channel activity and ex-
pression have been widely associated with apoptotic 
induction. And a previous study confirmed that the upregu-
lation of Kv1.5 was correlated with an increase in apoptosis 
and inhibition of PAH.1,4
Endothelin-1 (ET-1) has been implicated in the pathogen-
esis of pulmonary hypertension. And, there was clear evi-
dence of activation of the ET system in virtually all pre-clin-
ical models of PAH, as well as in all categories of human 
PAH.5 Its levels have been shown to be closely correlated 
with the severity of pulmonary vascular remodeling.6 Inter-
estingly, it was reported that extracellular application of 
ET-1 significantly reduced the amplitude of currents gener-
ated by K+ efflux through Kv1.5 channels. The inhibitory 
effect of ET-1 on Kv1.5 channels provided convincing evi-
dence that the mitogenic effect of ET-1 may partially result 
from its inhibition of Kv1.5 channels in human PASMCs.7
Fluoxetine, the highly selective 5-hydroxytryptamine 
transporter (5-HTT) inhibitor, was reported to confer partial 
protection from PAH in chronically hypoxic mice.8 Intrigu-
ingly, fluoxetine was recently reported to prevent and re-
verse established PAH in monocrotaline (MCT)-induced 
hypertensive rats.9-11 In addition, it was also reported that 
the protective effect of fluoxetine against MCT-induced hy-
pertension was potentially by upregulating Kv1.5 channels 
in rat. Therefore, the current study was designed to test the 
hypothesis that the antiproliferative and protective effects 
of fluoxetine are partially due to the upregulation of Kv1.5 
channels and subsequent promotion of apoptosis in human 
PASMCs cultured in vitro.
MATERIALS AND METHODS
　　　
Cell preparation and culture
Human PASMCs from normal subjects were purchased from 
ATCC (Rockefeller, Mali organization, Manassas, VA, USA) 
and used at passages 6-8. PASMCs were cultured in Dulbec-
co’s Modified Eagle Medium (DMEM) supplemented with 
10% fetal bovine serum (FBS), and maintained at 37°C in a 
humidified atmosphere of 5% CO2 in air. The growth of the 
cells was arrested by replacing 10% FBS DMEM with FBS-
free DMEM for 24 hours. The cells were then incubated 
with low-serum DMEM (2% FBS), ET-1 (Enzo ALEXIS, FeiFeng Dai, et al.
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as 100%, and the results for the ET-1, F with or without ET-1 
groups were expressed as a percentage of the value from the 
Blank group.
Flow cytometry
All samples were immunostained according to the protocol 
of the Annexin V/PI apoptosis kit. The apoptosis ratio was 
analyzed using flow cytometry.
Statistical analysis
All data are expressed as the mean±SEM. All experiments 
were performed at least with six independent Human PASMCs 
cultures. Statistical analyses were performed by one-way 
ANOVA. p-values <0.05 were considered significant.
 
RESULTS
 
Fluoxetine suppresses ET-1 induced human PASMCs 
proliferation
Plasma and lung ET-1 expression were increased in PAH, 
and correlated with disease severity, including the degree of 
PASMC proliferation.17 Fig. 1 shows the time course of hu-
man PASMC proliferation mediated by 2% FBS (Blank) 
TRPC1 proteins were detected using a standard Western blot 
protocol. Briefly, 30 μg proteins were separated by 8% SDS 
PAGE at 100 V for 0.5 hour and 80 V for 1.5 hours, and then 
transferred to a nitrocellulose membrane (Millipore, Billeri-
ca, MA, USA) at 4°C, 200 mA for 1 hour by a Western blot 
apparatus (Bio-Rad). The transferred membrane was blocked 
with 10% skimmed milk for 1 hour at room temperature, and 
then the blocked membrane was incubated with a primary 
antibody against Kv1.5 (dilution 1 : 700; Santa Cruz Bio-
technology, Santa Cruz, CA, USA), TRPC1 (dilution 1 : 400; 
Santa Cruz Biotechnology) and GAPDH (dilution 1 : 700; 
Santa Cruz Biotechnology) overnight at 4°C, respectively. 
After incubation with the horseradish peroxidase-conjugated 
secondary antibody (dilutions of 1 : 5000; Beijing Zhong 
Shan-Golden Bridge Biological Technology Company, Bei-
jing, China) for 1 hour at room temperature, the immunoblot-
ting signals were visualized using a Western Luminescent 
Detection kit (Vigorous Biotechnology, Beijing, China). The 
results were quantified by densitometry and the density of 
immunoblotting was analyzed by scanning X-ray film with 
Quantitative One software. The values of the relative density 
of the Kv1.5 and TRPC1 bands were normalized to the den-
sity of GAPDH to represent the amount of Kv1.5 and 
TRPC1 protein. The ratio of the Blank group was regarded 
Fig. 1. Fluoxetine mediated anti-proliferation of human PASMCs against ET-1. (A) Time course of the 2% FBS (Blank) and ET-1 (0.01 to 1 μM) induced human 
PASMCs proliferation (B). (C) The anti-proliferation of fluoxetine in a dose-dependent manner against ET-1 (0.1 μM). (D) The approximate proliferation be-
tween the 2% FBS and fluoxetine (1.0 μM) treated groups, induced by ET-1 (0.1 μM ). PASMCs, pulmonary arterial smooth muscle cells; FBS, fetal bovine se-
rum; ET-1, endothelin-1; MTT, multiply-table tournament.
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(Fig. 1A) and ET-1 at concentrations of 0.01 to 1 μM (Fig. 
1B). As shown in Fig. 1C, fluoxetine inhibited ET-1 (0.1 μM)-
mediated increase of human PASMC numbers at the concen-
trations of 0.1 to 10 μM. Since the concentration of 1 μM 
fluoxetine suppressed proliferation approximately to that of 
seen in 2% FBS (Blank), shown in Fig. 1D, this concentra-
tion was used as the proper inhibitory dose. So, the final 
concentrations of ET-1 and fluoxetine were set at 0.1 μM 
and 1.0 μM, separately. 
Fluoxetine suppresses ET-1 induced upregulation of 
TRPC1 in human PASMCs
It has been reported that the activity and expression level of 
TRPC1 protein is directly correlated to [Ca2+]i. In the present 
study, fluoxetine suppressed the expression of the TRPC1 
protein induced by ET-1. In Fig. 2, the expression of the 
TRPC1 markedly increased in the ET-1 induced group com-
pared with the Blank (1.2448±0.2157 vs. 0.6572±0.1076, 
p<0.01). However, when treated with fluoxetine, it was down 
regulated in the ET-1 induced group (0.7904±0.1043 vs. 
1.2448±0.2157, p<0.05). 
Fluoxetine upregulates the expression level of Kv1.5 in 
ET-1 mediated human PASMCs
Pulmonary Kv1.5 channels are supposed to play a key role in 
Fig. 2. Fluoxetine down regulated the expression of TRPC1 protein in ET-1 
induced human PASMCs. Western blot results are displayed for TRPC1 (92 
kDa) and GAPDH (34 kDa) in the human PASMCs cultured with low-serum 
DMEM (2% FBS, Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1 
(F) for 72 hours. Data, normalized to the amount of actin, are expressed as 
mean±SEM (n=7). *p<0.01 vs. Blank, 
†p<0.05 vs. ET-1. PASMCs, pulmonary 
arterial smooth muscle cells; FBS, fetal bovine serum; TRPC, transient re-
ceptor potential channels; ET-1, endothelin-1; GAPDH, glyceraldehydes 
phosphate dehydrogenase; SEM, standard error of mean.
Fig. 4. Fluoxetine reversed the level of Kv1.5 protein in ET-1 induced human 
PASMCs. Western blot results are displayed for Kv1.5 (57-59 kDa) and 
GAPDH (34 kDa) in the human PASMCs cultured with low-serum DMEM 
(2% FBS, Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 
72 h. Data, normalized to the amount of actin, are expressed as mean±SEM 
(n=9). *p<0.001 vs. Blank, 
†p<0.001 vs. ET-1. PASMCs, pulmonary arterial 
smooth muscle cells; FBS, fetal bovine serum; ET-1, endothelin-1; GAPDH, 
glyceraldehydes phosphate dehydrogenase; DMEM, dulbecco’s modified 
eagle medium; SEM, standard error of mean.
Fig. 3. Fluoxetine rescued the expression of Kv1.5 mRNA that was down 
regulated by ET-1 in human PASMCs. PCR amplified products are dis-
played for Kv1.5 (306 bp) and GAPDH (232 bp) in the human PASMCs cul-
tured with low-serum DMEM (2% FBS, Blank), ET-1, and fluoxetine with 
(ET-1+F) and without ET-1(F) for 72 hours. Data, normalized to the amount of 
GAPDH, are expressed as mean±SEM (n=7). *p<0.05 vs. Blank, 
†p<0.001 vs. 
ET-1, 
‡p<0.001 vs. Blank. PASMCs, pulmonary arterial smooth muscle cells; 
ET-1, endothelin-1; GAPDH, glyceraldehydes phosphate dehydrogenase; 
DMEM, dulbecco’s modified eagle medium; SEM, standard error of mean; 
PCR, polymerase chain reaction.
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the fluoxetine treatment group in contrast with the ET-1 in-
duced group (4.85±0.3852 vs. 1.1±0.1634, p<0.001). Also, 
there were no obvious changes between the Blank and fluox-
etine only groups (2.2±0.1707 vs. 2.3834±0.0703, p>0.05).
DISCUSSION
Pulmonary arterial hypertension is characterized by elevated 
pulmonary vascular resistance, smooth muscle remodeling 
and apoptosis, leading to right heart failure and death.4,12 Lu-
men narrowing and medial hypertrophy of small-sized pul-
monary arteries are hallmarks of the pulmonary vascular re-
modeling process, which are mainly due to an increased 
number of pulmonary arterial smooth muscle cells.13,14 The 
imbalance between proliferation and apoptosis results in an 
augmentation on the number of PASMCs.4 Therefore, pre-
cise control of the balance between PASMC proliferation and 
apoptosis is important to maintaining the structural and func-
tional integrity of the pulmonary vasculature. Guignabert, et 
al.9 confirmed the efficacy of fluoxetine in preventing and re-
versing pulmonary vascular remodeling in rats, which made 
fluoxetine a novel speculative therapeutic option for PAH. 
The protection of fluoxetine against PAH in MCT-induced 
rats was also previously demonstrated.10,11 In the present 
the processes of proliferation and apoptosis. Results from 
semiquantitative RT-PCR analysis showed that the mRNA 
expression of Kv1.5 in ET-1 induced human PASMCs was 
decreased remarkably, similar to the protein expression seen 
with the Western blots. In Fig. 3, ET-1 significantly decreased 
the expression of Kv1.5 mRNA compared with the Blank 
(0.0303±0.0034 vs. 0.0661±0.0051, p<0.05), as well as the 
Kv1.5 protein (1.2198±0.1016 vs. 2.5717±0.1557, p<0.001), 
as seen in Fig. 4. Compared with the ET-1 induced group, 
the same mRNA and protein were increased remarkably in 
the fluoxetine treatment group (0.1648±0.0087 vs. 0.0303± 
0.0034, p<0.001; 2.1234±0.1766 vs. 1.2198±0.1016, sepa-
rately, p<0.001). Although the Kv1.5 mRNA level was in-
creased in the F group, compared with the Blank (0.1305± 
0.01478 vs. 0.0661±0.0051, p<0.01), the expression of 
Kv1.5 protein demonstrated no difference (2.5717±0.1557 
vs. 2.2290±0.0337, p>0.05). 
Fluoxetine promotes the apoptosis ratio of ET-1 
induced human PASMCs
The early stages of apoptosis in the human PASMCs treated 
above were detected by Flow Cytometry. Compared with the 
Blank, as shown in Fig. 5 and Fig. 6, ET-1 induced apoptosis 
inhibition was enhanced (1.1±0.1634 vs. 2.3834±0.0703, 
p<0.01). Apparently, the apoptosis ratio was increased in 
Fig. 5. Fluoxetine enhanced the apoptosis ratio in ET-1induced human 
PASMCs. The result from Flow Cytometry are displayed for the ratio of 
apoptosis in the human PASMCs cultured with low-serum DMEM (2% FBS, 
Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 72 h. 
PASMCs, pulmonary artery smooth muscle cells; FBS, fetal bovine serum; 
ET-1, endothelin-1; DMEM, dulbecco’s modified eagle medium; PI, 
Propidium Iodide. FITC, fluoresceine isothiocyanate.
Fig. 6. Fluoxetine enhanced the apoptosis ratio in ET-1induced human 
PASMCs. The result from Flow Cytometry are displayed for the ratio of 
apoptosis in the human PASMCs cultured with low-serum DMEM (2% FBS, 
Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 72 h. Data 
are expressed as mean±SEM (n=6). *p<0.01 vs. Blank, 
†p<0.001 vs. ET-1. 
PASMCs, pulmonary artery smooth muscle cells; FBS, fetal bovine serum; 
ET-1, endothelin-1; DMEM, dulbecco’s modified eagle medium; SEM, stan-
dard error of mean.
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stages was decreased, paralleling with the downregulation 
of Kv1.5 channels. Impressively, the human PASMCs treat-
ed with fluoxetine only changed in the mRNA expression 
of Kv1.5, but no changes on the expression of protein was 
observed, paralleling with the apoptosis ratio, compared 
with the Blank. 
A detailed mechanism of the development of PAH is not 
yet known. The results from the present study showed that 
fluoxetine plays an important role in rescuing the expres-
sion of Kv1.5 channel in the ET-1 induced group. Potential-
ly, the pharmacological blockade of 5-HTT may inhibit the 
activation of Ras/Rac system, down regulating the levels of 
TRPC1 and [Ca2+]i and rescue Kv1.5 channels.
In conclusion, fluoxetine plays an important role in im-
proving pulmonary vascular remodeling, by suppressing pro-
liferation, rescuing Kv1.5 channels and promoting apoptosis.
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